ArticlePloS one2026
Development and validation of the 6-dye lyophilized fluorescent multiplex PCR system.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aiming to address the issues associated with traditional liquid STR reagents-such as dependence on cold-chain storage, cumbersome operation, and unsuitability for on-site rapid detection-this study has successfully developed a six-color fluorescent lyophilized multiplex amplification reagent. The reagent includes 29 autosomal STR loci and 1 gender identification locus. By screening high-tolerance Taq polymerase, optimizing lyoprotectant formulations, and developing a lyophilization process based on thermodynamic analysis, stable ambient-temperature storage of key reagent components has been achieved. Performance validation demonstrates that the lyophilized reagent exhibits high sensitivity (100% detection at 0.125 ng DNA), remains stable for 60 days at room temperature, rehydrates rapidly (<1 second), and shows some tolerance to common inhibitors. Benefiting from the "whole-volume loading" advantage, its detection capability for trace samples surpasses that of traditional liquid reagents. In parallel comparison with similar liquid reagents, it achieves completely consistent locus detection rates (100%), fully meeting the requirements for individual identification. With simple operation and a ready-to-use, disposable design, this reagent effectively overcomes the reliance on cold-chain logistics. It provides robust technical and reagent support for rapid on-site forensic testing, emergency response, grassroots applications, and DNA database construction, demonstrating significant application prospects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.